Victrex plc (LON:VCT - Get Free Report)'s stock price dropped 8.4% on Wednesday after Deutsche Bank Aktiengesellschaft downgraded the stock to a hold rating. Deutsche Bank Aktiengesellschaft now has a GBX 850 price target on the stock, down from their previous price target of GBX 990. Victrex traded as low as GBX 667.62 ($9.01) and last traded at GBX 720 ($9.71). Approximately 827,259 shares were traded during mid-day trading, an increase of 97% from the average daily volume of 420,250 shares. The stock had previously closed at GBX 786 ($10.60).
Separately, JPMorgan Chase & Co. cut their target price on Victrex from GBX 940 ($12.68) to GBX 818 ($11.03) and set a "neutral" rating for the company in a research note on Wednesday.
Read Our Latest Analysis on Victrex
Insider Buying and Selling
In other Victrex news, insider Dame Vivienne Cox bought 2,747 shares of Victrex stock in a transaction that occurred on Tuesday, July 8th. The shares were bought at an average cost of GBX 721 ($9.73) per share, with a total value of £19,805.87 ($26,717.75). Also, insider David Thomas acquired 1,158 shares of the business's stock in a transaction dated Tuesday, May 13th. The stock was purchased at an average cost of GBX 846 ($11.41) per share, for a total transaction of £9,796.68 ($13,215.54). Insiders own 1.64% of the company's stock.
Victrex Price Performance
The company has a current ratio of 4.39, a quick ratio of 1.99 and a debt-to-equity ratio of 10.93. The stock has a market cap of £631.91 million, a PE ratio of 20.58, a P/E/G ratio of 1.92 and a beta of 0.69. The company has a fifty day moving average of GBX 793.01 and a 200-day moving average of GBX 887.05.
Victrex (LON:VCT - Get Free Report) last released its earnings results on Monday, May 12th. The company reported GBX 22.60 ($0.30) EPS for the quarter. Victrex had a return on equity of 6.67% and a net margin of 10.81%. Sell-side analysts expect that Victrex plc will post 73.1078905 EPS for the current fiscal year.
About Victrex
(
Get Free Report)
Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Sustainable Solutions and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also provides specialist solutions for medical device manufacturers; sells thermoplastic polymers; sustainable solutions for energy and industrial, VAR, automotive, aerospace, and electronics markets; and engages in trading activities.
See Also
Before you consider Victrex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Victrex wasn't on the list.
While Victrex currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
